相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Treatment of Multidrug-Resistant Gram-Negative Infections in Children
Alice J. Hsu et al.
CLINICAL INFECTIOUS DISEASES (2014)
The Use of Cefepime for Treating AmpC β-Lactamase-Producing Enterobacteriaceae
Pranita D. Tamma et al.
CLINICAL INFECTIOUS DISEASES (2013)
Background and Rationale for Revised Clinical and Laboratory Standards Institute Interpretive Criteria (Breakpoints) for Enterobacteriaceae and Pseudomonas aeruginosa: I. Cephalosporins and Aztreonam
Michael N. Dudley et al.
CLINICAL INFECTIOUS DISEASES (2013)
β-Lactam/β-Lactam Inhibitor Combinations for the Treatment of Bacteremia Due to Extended-Spectrum β-Lactamase-Producing Escherichia coli: A Post Hoc Analysis of Prospective Cohorts
Jesus Rodriguez-Bano et al.
CLINICAL INFECTIOUS DISEASES (2012)
Can We Really Use ß-Lactam/ß-Lactam Inhibitor Combinations for the Treatment of Infections Caused by Extended-Spectrum ß-Lactamase-Producing Bacteria?
Federico Perez et al.
CLINICAL INFECTIOUS DISEASES (2012)
Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy
Mario Tumbarello et al.
CLINICAL INFECTIOUS DISEASES (2012)
Antimicrobial susceptibility of Enterobacteriaceae, including molecular characterization of extended-spectrum beta-lactamase-producing species, in urinary tract isolates from hospitalized patients in North America and Europe: results from the SMART study 2009-2010
Daryl J. Hoban et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2012)
Risk Factors for Gastrointestinal Tract Colonization with Extended-Spectrum β-Lactamase (ESBL)-Producing Escherichia coli and Klebsiella Species in Hospitalized Patients
Jennifer H. Han et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2012)
Extended-Spectrum β-Lactamase Producers Reported as Susceptible to Piperacillin-Tazobactam, Cefepime, and Cefuroxime in the Era of Lowered Breakpoints and No Confirmatory Tests
Dror Marchaim et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2012)
An Outbreak of Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae in a Neonatal Intensive Care Unit
Pranita D. Tamma et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2012)
Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum -lactamases: a systematic review and meta-analysis
Konstantinos Z. Vardakas et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region according to currently established susceptibility interpretive criteria
Yen-Hsu Chen et al.
JOURNAL OF INFECTION (2011)
Susceptibility of Gram-Negative Pathogens Isolated from Patients with Complicated Intra-Abdominal Infections in the United States, 2007-2008: Results of the Study for Monitoring Antimicrobial Resistance Trends (SMART)
Daryl J. Hoban et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin-clavulanate and piperacillin-tazobactam with extended-spectrum β-lactamase-producing and extended-spectrum β-lactamase-non-producing Escherichia coli isolates
L. Lopez-Cerero et al.
CLINICAL MICROBIOLOGY AND INFECTION (2010)
Carbapenem Resistance Among Klebsiella pneumoniae Isolates: Risk Factors, Molecular Characteristics, and Susceptibility Patterns
Khetam Hussein et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2009)
The epidemic of antibiotic-resistant infections: A call to action for the medical community from the Infectious Diseases Society of America
Brad Spellberg et al.
CLINICAL INFECTIOUS DISEASES (2008)
Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Infection and the Impact of Antimicrobial and Adjunctive Therapies
Gopi Patel et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2008)
Risk factors for colonization with extended-spectrum β-lactamase-producing bacteria and intensive care unit admission
Anthony D. Harris et al.
EMERGING INFECTIOUS DISEASES (2007)
Predictors of mortality in patients with bloodstream infection due to ceftazidime-resistant Klebsiella pneumoniae
DJ Anderson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Extended-spectrum β-lactamases:: a clinical update
DL Paterson et al.
CLINICAL MICROBIOLOGY REVIEWS (2005)
Proteus mirabilis bloodstream infections:: Risk factors and treatment outcome related to the expression of extended-spectrum β-lactamases
A Endimiani et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae -: Variability by site of infection
EP Hyle et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
International prospective study Klebsiella pneumoniae bacteremia:: Implications of extended-spectrum β-lactamase production in nosocomial infections
DL Paterson et al.
ANNALS OF INTERNAL MEDICINE (2004)
Antibiotic therapy for Klebsiella pneumoniae bacteremia:: Implications of production of extended-spectrum β-lactamases
DL Paterson et al.
CLINICAL INFECTIOUS DISEASES (2004)
Bloodstream infections due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae:: Risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy
CI Kang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum β-lactamase-producing Enterobacteriaceae
KS Thomson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae:: Risk factors for infection and impact of resistance on outcomes
E Lautenbach et al.
CLINICAL INFECTIOUS DISEASES (2001)
分享论文
